Clinical Trial Update: A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease [Phase 2]

View source ↗

Summary

Phase 2 trial updating the effects of RO4607381 on atherosclerotic plaque in patients with coronary heart disease; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• RO4607381

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Coronary Heart Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-01-03